TipHub

26.6

+0.84 +3.26%

29 Jul 2026

BSE Listed

LT-ASM · ASM 1
What does LT-ASM · ASM 1 mean?
BSE · Long Term Additional Surveillance Measure (ASM 1)LT-ASM is the joint SEBI/exchange framework for SUSTAINED abnormal price moves (contrast ST-ASM's 5–15-day spikes). Entry is beta-adjusted price variation versus the Nifty (e.g. 3-month high-low above 150% plus the stock's β × index move) along with client-concentration checks. Stages I–IV escalate from a 5% price band through 100% margin to Trade-for-Trade with an additional surveillance deposit. Practical meaning: the exchange still considers the price action abnormal — tighter bands and elevated margins continue even if another measure (like ESM) has lifted. A stock can sit under LT-ASM on both exchanges via either exchange's shortlisting; it is a preventive cost-of-speculation measure, not an adverse finding against the company.Criteria: High 3-month / 12-month high-low price variation, close-to-close price variation, client concentration, number of price-band hits, market-wide position limit and P/E — applied in graded Stages I–IV with escalating margin and price-band curbs.Exchange notice · 2026-06-25

Medico Intercontinental Limited (539938)

Volume: 252Avg Vol 1W: 1,819Avg Vol 1M: 1,56152W Range:20.6143
Key Ratios
Checked 3h ago
Market Cap₹24 Cr
Current Price₹26.6
Previous Close₹25.76
High / Low (52w)₹43 / ₹20.61
Volume252
Avg Vol (1W)1,819
Avg Vol (1M)1,561
Stock P/E
Book Value₹46.89
Dividend Yield0%
ROE-6.83%
ROA-9.43%
Revenue (TTM)
Revenue Growth
Profit Margin-380.54%
Total Debt
Shares Outstanding1 Cr
Face Value
EPS (TTM)₹0
P/B0.51
Debt / Equity0.23
50 DMA₹25.86
200 DMA₹30.77
Day change+3.26%
SurveillanceLT-ASM · ASM 1
Price Chart
26.6 29.48% · 1Y
44214.4L
2025-07-29
2026-07-29

20-day avg volume: 1K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 24% YoY.
  • Stock trades below its book value.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹19 Cr₹36 Cr₹18 Cr₹21 Cr₹21 Cr₹20 Cr₹20 Cr₹22 Cr
EBITDA₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹0 Cr₹-2 Cr₹1 Cr₹0 Cr
Net Profit₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹-1 Cr₹-2 Cr₹0 Cr₹-1 Cr
EPS
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹29 Cr₹11 Cr₹96 Cr₹15 Cr₹13 Cr₹12 Cr₹13 Cr₹16 Cr
EBITDA₹2 Cr₹1 Cr₹8 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr
Net Profit₹1 Cr₹1 Cr₹5 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹0 Cr
EPS5.06
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹4 Cr₹9 Cr₹36 Cr₹31 Cr₹32 Cr₹59 Cr₹56 Cr₹76 Cr
Total Liabilities₹1 Cr₹5 Cr₹30 Cr₹21 Cr₹19 Cr₹18 Cr₹11 Cr₹27 Cr
Equity₹3 Cr₹4 Cr₹6 Cr₹10 Cr₹13 Cr₹41 Cr₹45 Cr₹49 Cr
Total Debt
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹1 Cr₹-9 Cr₹7 Cr₹5 Cr₹-9 Cr₹7 Cr₹-5 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹-1 Cr₹-5 Cr₹-9 Cr₹-2 Cr
Financing₹0 Cr₹0 Cr₹13 Cr₹-5 Cr₹-1 Cr₹20 Cr₹0 Cr₹9 Cr
Free Cash Flow₹0 Cr₹1 Cr₹-9 Cr₹7 Cr₹5 Cr₹-9 Cr₹7 Cr₹-5 Cr
Shareholding
Promoter 58.51% Institutions 0% Public 41.49%
Efficiency & Working Capital
ROCE-1%
Interest Coverage8
Dividend Payout
Debtor Days125 d
Inventory Days35 d
Payable Days28 d
Cash Conversion Cycle132 d
Working Capital Days160 d
Shareholding Details

As of 2026-06-30

Promoter58.5%
FII0%
DII0%
Institutions0%
Public41.5%
Promoter Pledge0%
No. of Shareholders3,489
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters54.8%55.1%55.1%55.1%55.1%55.2%55.2%55.2%55.2%57.1%57.1%58.5%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public45.2%44.9%44.9%44.9%44.9%44.8%44.8%44.8%44.8%42.9%42.9%41.5%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,1341,1193,4993,4653,5773,7593,7313,6963,6253,5753,4993,489
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Shah SamirShareholding of Promoter and Promoter Group47.8%47,76,999
Dilipkumar Bhogilal ShahShareholding of Promoter and Promoter Group10.7%10,74,397
Lalita .Public Shareholding1.5%1,50,000
Dd Master Huf .Public Shareholding1.2%1,23,575
Board of Directors
NameDesignationYear
Tanvi ShahChairman & Non Executive Dir.2025
Samir ShahExecutive Director & MD2025
Ankur DaveIndependent Non Exe. Director2025
Priyank Lalitbhai SanchetiIndependent Non Exe. Director2025
Swati Vikramkumar ShahNon Executive Director2025
Parshwa Kaushal ShahIndependent Non Exe. Director2025
Puneeta SharmaCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Trading₹68 Cr100%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10201010
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202560612841
2025003003
2025000000
Insider / Designated-Person Trades

2 recent disclosure(s)

SAMIR DILIPKUMAR SHAHAcquisition · 1,36,886
SAMIR DILIPKUMAR SHAHAcquisition · 1,97,285
Substantial Acquisitions (SAST)

1 disclosure(s)

Market24/12/2025 · 1,97,285
Company Information
Incorporated1984
ChairmanTanvi Shah
AuditorV Goswami & Co
Investor Email[email protected]
🌐 www.medicointercontinental.com

📍 213 2nd Floor, Raheja Chambers Nariman Point, Mumbai, Maharashtra, 400021

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search